Patrick J. McEnany - 28 Dec 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
28 Dec 2021
Net transactions value
$0
Form type
4
Filing time
30 Dec 2021, 15:48:59 UTC
Previous filing
06 Dec 2021
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +270,000 +8.4% $0.000000 3,490,834 28 Dec 2021 Common Stock 270,000 $7.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest in equal tranches, 1/3rd on December 28, 2022, 1/3rd on December 28, 2023 and 1/3rd on December 28, 2024.